Thu, Dec 25, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Malta Financial Services Authority highlights facility for Maltese funds to sell to China

Monday, February 04, 2013

Beverly Chandler, Opalesque London: The January newsletter for the Maltese financial community from the Malta Financial Services Authority highlights the fact that Malta domiciled institutional investors licenced by the MFSA have the opportunity to sell investment funds to Chinese institutional investors.

The MFSA writes: "This is a result of a bilateral Memorandum of Understanding (MoU) on securities and futures regulatory cooperation signed on 26th January 2010 in Malta, with the MFSA and the China Securities Regulatory Commission (CSRC). A similar agreement was signed with the China Banking Regulatory Commission (CBRC). Chinese institutional investors must have a Qualifying Domestic Institutional Investor (QDII) status to be eligible to access the local market. The QDII status is a scheme relating to Chinese capital market outflows set up to allow authorised financial institutions of Chinese domiciliation to invest in overseas markets that hold a bi-lateral MoU with the Chinese regulatory Commission."

Useful information for Maltese firms includes:

  • Chinese institutional investors, including commercial banks, securities companies, fund companies, insurance companies and trust funds, must hold a QDII licence from the respective Chinese regulatory Commissions, namely China Security Regulatory Commission (CSRC); China Banking Regulatory Commission (CBRC); or China Insurance Regulatory Commission (CIRC). The Chine......................

    To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its